ARGOS THERAPEUTICS INC License Agreements
9 Contracts & Agreements
- Letter from the Registrant to Medinet Co., Ltd., dated February 14, 2018, regarding revocation of certain rights under the novated, amended and restated license agreement (Filed With SEC on May 15, 2018)
- Third Amendment to License Agreement, dated March 23, 2018, between Registrant and Lummy (Hong Kong) Co., Ltd (Filed With SEC on April 2, 2018)
- Second Amendment to License Agreement, dated October 18, 2017, between Registrant and Lummy (Hong Kong) Co., Ltd (Filed With SEC on April 2, 2018)
- First Amendment to License Agreement, dated December 5, 2016, by and between Registrant and Lummy (Hong Kong) Co., Ltd (Filed With SEC on May 10, 2017)
- LICENSE AGREEMENT (Filed With SEC on February 10, 2012)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on July 29, 2011)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT (Anti-Interferon Alpha... (Filed With SEC on July 29, 2011)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT - TREATING AUTOIMMUNE... (Filed With SEC on July 29, 2011)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on July 29, 2011)
